Professor James Bishop

AO
Honorary Professor
Medicine, Central Clinical School


Map

Selected publications

Download citations: PDF RTF Endnote

Journals

  • Olver, I., Falleiro, S., Marson, M., Bishop, J. (2011). A case study of a single ethics committee for multicentre trials. Medical Journal of Australia, 195(10), 582-583. [More Information]
  • Cotter, T., Hung, W., Perez, D., Dunlop, S., Bishop, J. (2011). Squeezing new life out of an old Sponge: how to modernise an anti-smoking media campaign to capture a new market. Australian and New Zealand Journal of Public Health, 35(1), 75-80. [More Information]
  • Rivory, L., Clarke, S., Boyer, M., Bishop, J. (2001). Highly sensitive analysis of the antifolate pemetrexed sodium, a new cancer agent, in human plasma and urine by high-performance liquid chromatography. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences, 765, 135-140.
  • Clarke, S., Bishop, J., Dodds, H., Rivory, L., Ong,, S. (2001). Toxicity of irinotecan (CPT-11) and hepato-renal dysfunction. Anti-Cancer Drugs, 12, 619-625.
  • Rischin, D., Boyer, M., Smith, J., Millward, M., Michael, M., Bishop, J., Zalcberg, J., Davison, J., Emmett, E., McClure, B. (2000). A phase I trial of docetaxel and gemcitabine in patients with advanced cancer. Annals of Oncology, 11, 421-426.
  • Rivory, L., Qin, H., Clarke, S., Eris, J., Duggin, G., Ray, E., Trent, R., Bishop, J. (2000). Frequency of cytochrome P450 3A4 variant genotype in transplant population and lack of association with cyclosporin clearance. European Journal of Clinical Pharmacology, 56, 395-398.
  • Rivory, L., Charles (nee Slaviero), K., Seale, J., Hoskins, J., Boyer, M., Beale, P., Millward, M., Bishop, J., Clarke, S. (2000). Optimizing the erythromycin breath test for use in cancer patients. Clinical Cancer Research, 6, 3480-3485.

2011

  • Olver, I., Falleiro, S., Marson, M., Bishop, J. (2011). A case study of a single ethics committee for multicentre trials. Medical Journal of Australia, 195(10), 582-583. [More Information]
  • Cotter, T., Hung, W., Perez, D., Dunlop, S., Bishop, J. (2011). Squeezing new life out of an old Sponge: how to modernise an anti-smoking media campaign to capture a new market. Australian and New Zealand Journal of Public Health, 35(1), 75-80. [More Information]

2001

  • Rivory, L., Clarke, S., Boyer, M., Bishop, J. (2001). Highly sensitive analysis of the antifolate pemetrexed sodium, a new cancer agent, in human plasma and urine by high-performance liquid chromatography. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences, 765, 135-140.
  • Clarke, S., Bishop, J., Dodds, H., Rivory, L., Ong,, S. (2001). Toxicity of irinotecan (CPT-11) and hepato-renal dysfunction. Anti-Cancer Drugs, 12, 619-625.

2000

  • Rischin, D., Boyer, M., Smith, J., Millward, M., Michael, M., Bishop, J., Zalcberg, J., Davison, J., Emmett, E., McClure, B. (2000). A phase I trial of docetaxel and gemcitabine in patients with advanced cancer. Annals of Oncology, 11, 421-426.
  • Rivory, L., Qin, H., Clarke, S., Eris, J., Duggin, G., Ray, E., Trent, R., Bishop, J. (2000). Frequency of cytochrome P450 3A4 variant genotype in transplant population and lack of association with cyclosporin clearance. European Journal of Clinical Pharmacology, 56, 395-398.
  • Rivory, L., Charles (nee Slaviero), K., Seale, J., Hoskins, J., Boyer, M., Beale, P., Millward, M., Bishop, J., Clarke, S. (2000). Optimizing the erythromycin breath test for use in cancer patients. Clinical Cancer Research, 6, 3480-3485.

To update your profile click here. For support on your academic profile contact .